DPP4 and autoimmune disease: Inhibition of DPPIV/CD26 suppresses antigen-stimulated T cell proliferation and cytokine production, thus suggesting a potential application for DPPIV inhibitors as immunomodulatory drugs in autoimmune diseases [15].